BRIEF published on 08/06/2024 at 22:10, 1 year 7 months ago Nyxoah Reports Financial Results for Q2 and H1 2024 Revenue Growth Capital Raise Operational Highlights FDA Submission Q2 2024 Results
PRESS RELEASE published on 08/06/2024 at 22:05, 1 year 7 months ago Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results Nyxoah SA reports financial and operating results for the second quarter and first half of 2024, including FDA submission completion and U.S. approval progress Financial Results Operating Results FDA Submission Nyxoah SA U.S. Approval
BRIEF published on 07/15/2024 at 08:20, 1 year 8 months ago Nyxoah Appoints Scott Holstine as Chief Commercial Officer FDA Approval Medical Device Industry Nyxoah Obstructive Sleep Apnea Scott Holstine
PRESS RELEASE published on 07/15/2024 at 08:15, 1 year 8 months ago Nyxoah Appoints Scott Holstine as Chief Commercial Officer Nyxoah appoints Scott Holstine as Chief Commercial Officer, bringing 26 years of medical device industry experience. His role is crucial for Nyxoah's U.S. launch success in treating Obstructive Sleep Apnea Chief Commercial Officer Medical Technology Nyxoah Obstructive Sleep Apnea Scott Holstine
BRIEF published on 07/03/2024 at 12:35, 1 year 8 months ago Nyxoah Signs €37.5 Million Loan Agreement with European Investment Bank Loan Agreement Medical Technology European Investment Bank Nyxoah Obstructive Sleep Apnea
PRESS RELEASE published on 07/03/2024 at 12:30, 1 year 8 months ago Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank Nyxoah signs a €37.5 million loan facility agreement with the European Investment Bank to boost research, development, and manufacturing capacity for sleep apnea solutions Research And Development European Investment Bank Sleep Apnea Nyxoah €37.5 Million Loan
Published on 03/16/2026 at 19:55, 27 minutes ago GGL Resources Corp. Updates the Status of its Earn-In Agreement on its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/16/2026 at 18:12, 2 hours 10 minutes ago Sekur Private Data Signs Distribution Agreement In Africa
Published on 03/16/2026 at 14:00, 6 hours 22 minutes ago Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression
Published on 03/16/2026 at 13:45, 6 hours 37 minutes ago iFabric Corp Provides Strong 2025 Revenue Estimate and 2026 Outlook
Published on 03/16/2026 at 13:30, 6 hours 52 minutes ago Ondas Completes Acquisition of Rotron Aerospace Ltd., Expanding Long-Range Propulsion Technologies for Advanced Unmanned Systems for Defense
Published on 03/16/2026 at 19:50, 32 minutes ago EQS-Adhoc: Softing AG approves 10% cash capital increase excluding subscription rights
Published on 03/16/2026 at 19:45, 37 minutes ago EQS-Adhoc: Northern Data Announces FY 2025 preliminary Financial Results
Published on 03/16/2026 at 19:24, 57 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/16/2026 at 18:45, 1 hour 37 minutes ago Cognizant Expands AI Infrastructure Capabilities with Launch of Cognizant AI Factory
Published on 03/16/2026 at 18:26, 1 hour 56 minutes ago M&G Credit Income Investment Trust plc: Net Asset Value(s)
Published on 03/16/2026 at 18:00, 2 hours 22 minutes ago Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 2 hours 24 minutes ago Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 2 hours 25 minutes ago Reporting on share buyback transactions carried out between March 9 and March 13, 2026
Published on 03/16/2026 at 17:35, 2 hours 47 minutes ago Disclosure of transactions in own shares from March 9 to March 13, 2026
